CannTrust Holdings Inc. Stock Other OTC
Equities
CNTTQ
CA1378002077
Pharmaceuticals
Sales 2017 | 20.7 28.32 | Sales 2018 | 45.65 62.46 | Capitalization | 508M 695M |
---|---|---|---|---|---|
Net income 2017 | 6M 8.21M | Net income 2018 | -13M -17.79M | EV / Sales 2017 | 31,215,427 x |
Net cash position 2017 | 17.16M 23.49M | Net cash position 2018 | 58M 79.37M | EV / Sales 2018 | 9,864,003 x |
P/E ratio 2017 |
81.5
x | P/E ratio 2018 |
-34.5
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Greg Guyatt
CEO | Chief Executive Officer | - | 19-02-18 |
David Blair
DFI | Director of Finance/CFO | - | 19-09-30 |
Sales & Marketing | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Greg Guyatt
CEO | Chief Executive Officer | - | 19-02-18 |
Dan Hogan
BRD | Director/Board Member | - | 21-03-16 |
1st Jan change | Capi. | |
---|---|---|
+40.09% | 6.16B | |
-16.34% | 4.46B | |
-7.11% | 3.27B | |
+5.14% | 3.2B | |
-0.18% | 2.6B | |
+47.93% | 1.98B | |
-7.15% | 1.7B | |
+0.67% | 1.66B | |
-8.73% | 1.61B |